Dogwood Therapeutics Inc. (DWTX)
NASDAQ: DWTX
· Real-Time Price · USD
5.00
-0.36 (-6.72%)
At close: May 02, 2025, 3:59 PM
4.98
-0.40%
After-hours: May 02, 2025, 05:57 PM EDT
-6.72% (1D)
| Bid | 5.14 |
| Market Cap | 9.56M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -12.35M |
| EPS (ttm) | -12.52 |
| PE Ratio (ttm) | -0.4 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 5.14 |
| Volume | 150,341 |
| Avg. Volume (20D) | 1,833,758 |
| Open | 5.28 |
| Previous Close | 5.36 |
| Day's Range | 4.93 - 5.45 |
| 52-Week Range | 1.62 - 29.28 |
| Beta | 2.01 |
About DWTX
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, att...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 12
Stock Exchange NASDAQ
Ticker Symbol DWTX
Website https://www.dwtx.com
Analyst Forecast
According to 1 analyst ratings, the average rating for DWTX stock is "Buy." The 12-month stock price forecast is $10, which is an increase of 100.00% from the latest price.
Stock Forecasts1 month ago
-27.76%
Dogwood Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
1 month ago
+48.98%
Dogwood Therapeutics shares are trading higher as traders circulate a newsletter mention.
